HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
U Geisen Selected Research
U Geisen Research Topics
Disease
2
Hemophilia A (Haemophilia)
01/2016 - 11/2001
1
Hemorrhage
07/2010
1
Metabolic Syndrome (Dysmetabolic Syndrome X)
06/2009
1
Thromboembolism
10/2002
1
Disease Susceptibility (Diathesis)
05/2001
1
Venous Thromboembolism
05/2001
1
von Willebrand Diseases (von Willebrand's Disease)
04/2000
Drug/Important Bio-Agent (IBA)
2
factor V Leiden
IBA
10/2002 - 05/2001
2
Prothrombin (Factor II)
IBA
10/2002 - 11/2001
2
recombinant FVIIa (rFVIIa)
FDA Link
11/2001 - 04/2000
1
Neutralizing Antibodies
IBA
01/2016
1
Antibodies
IBA
01/2016
1
Autoantibodies
IBA
01/2016
1
Factor VIII (Coagulation Factor VIII)
IBA
01/2016
1
Immunoglobulin G (IgG)
IBA
01/2016
1
Warfarin (Coumadin)
FDA Link
Generic
07/2010
1
Heparin (Liquaemin)
FDA Link
Generic
07/2010
1
oxidized low density lipoprotein
IBA
06/2009
1
Simvastatin (Zocor)
FDA Link
Generic
06/2009
1
Fenofibrate (CiL)
FDA Link
Generic
06/2009
1
Ezetimibe (Zetia)
FDA Link
06/2009
1
Fluvastatin
FDA Link
06/2009
1
activated protein C receptor
IBA
10/2002
1
Endothelial Protein C Receptor
IBA
10/2002
1
Cystathionine beta-Synthase (Serine Sulfhydrase)
IBA
10/2002
1
Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)
IBA
10/2002
1
Factor Xa (Coagulation Factor Xa)
IBA
05/2001
1
Dalteparin (Dalteparin Sodium)
FDA Link
05/2001
1
Thrombin
FDA Link
05/2001
1
Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)
IBA
05/2001
1
von Willebrand Factor
IBA
04/2000
1
Isoantibodies
IBA
04/2000
Therapy/Procedure
1
Operative Surgical Procedures
07/2010
1
Therapeutics
07/2010